Neeli P - Search Results

1

DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice.

Chai D, Wang X, Neeli P, Zhou S, Yu X, Sabapathy K, Li Y. Chai D, et al. Among authors: neeli p. Genes Dis. 2023 Jun 23;11(4):100994. doi: 10.1016/j.gendis.2023.04.027. eCollection 2024 Jul. Genes Dis. 2023. PMID: 38560504 Free PMC article.

2

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects.

Lu B, Lim JM, Yu B, Song S, Neeli P, Sobhani N, K P, Bonam SR, Kurapati R, Zheng J, Chai D. Lu B, et al. Among authors: neeli p. Front Immunol. 2024 Feb 1;15:1332939. doi: 10.3389/fimmu.2024.1332939. eCollection 2024. Front Immunol. 2024. PMID: 38361919 Free PMC article. Review.

3

AI-powered discovery of a novel p53-Y220C reactivator.

Zhou S, Chai D, Wang X, Neeli P, Yu X, Davtyan A, Young K, Li Y. Zhou S, et al. Among authors: neeli p. Front Oncol. 2023 Aug 1;13:1229696. doi: 10.3389/fonc.2023.1229696. eCollection 2023. Front Oncol. 2023. PMID: 37593097 Free PMC article.

4

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.

Jiang N, Zheng Y, Ding J, Wang J, Zhu F, Wang M, Sobhani N, Neeli P, Wang G, Li H, Zheng J, Chai D. Jiang N, et al. Among authors: neeli p. NPJ Vaccines. 2023 Aug 4;8(1):109. doi: 10.1038/s41541-023-00706-x. NPJ Vaccines. 2023. PMID: 37542081 Free PMC article.

5

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2.

Neeli P, Chai D, Wang X, Sobhani N, Udeani G, Li Y. Neeli P, et al. iScience. 2023 Jun 16;26(7):107120. doi: 10.1016/j.isci.2023.107120. eCollection 2023 Jul 21. iScience. 2023. PMID: 37361876 Free PMC article.

6

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8⁺T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma.

Shi X, Ding J, Zheng Y, Wang J, Sobhani N, Neeli P, Wang G, Zheng J, Chai D. Shi X, et al. Among authors: neeli p. iScience. 2023 Feb 4;26(3):106143. doi: 10.1016/j.isci.2023.106143. eCollection 2023 Mar 17. iScience. 2023. PMID: 36879804 Free PMC article.

7

C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response.

Wang Q, Chai D, Sobhani N, Sun N, Neeli P, Zheng J, Tian H. Wang Q, et al. Among authors: neeli p. Front Physiol. 2022 Nov 17;13:1012112. doi: 10.3389/fphys.2022.1012112. eCollection 2022. Front Physiol. 2022. PMID: 36467687 Free PMC article. Review.

8

DOT1L regulates MTDH-mediated angiogenesis in triple-negative breast cancer: intermediacy of NF-κB-HIF1α axis.

Neeli PK, Sahoo S, Karnewar S, Singuru G, Pulipaka S, Annamaneni S, Kotamraju S. Neeli PK, et al. FEBS J. 2023 Jan;290(2):502-520. doi: 10.1111/febs.16605. Epub 2022 Sep 4. FEBS J. 2023. PMID: 36017623 Free article.

9

Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe^-/- mice.

Karnewar S, Pulipaka S, Katta S, Panuganti D, Neeli PK, Thennati R, Jerald MK, Kotamraju S. Karnewar S, et al. Among authors: neeli pk. Atherosclerosis. 2022 Sep;356:28-40. doi: 10.1016/j.atherosclerosis.2022.07.012. Epub 2022 Jul 20. Atherosclerosis. 2022. PMID: 35961209

10

Expanding anti-CD38 immunotherapy for lymphoid malignancies.

Wang X, Yu X, Li W, Neeli P, Liu M, Li L, Zhang M, Fang X, Young KH, Li Y. Wang X, et al. Among authors: neeli p. J Exp Clin Cancer Res. 2022 Jun 28;41(1):210. doi: 10.1186/s13046-022-02421-2. J Exp Clin Cancer Res. 2022. PMID: 35765110 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page